Literature DB >> 16839338

Role of fibronectin assembly in platelet thrombus formation.

J Cho1, D F Mosher.   

Abstract

Fibronectin is a component of subendothelial matrices and abundant in plasma. A role of fibronectin in thrombogenesis has been suspected for three decades. Soluble fibronectin is assembled by adherent fibroblasts and platelets and thus converted to an insoluble form that mediates cell adhesion. Recently, in vivo studies using intravital videomicroscopy revealed that plasma fibronectin is important for stabilization of platelet aggregates after vascular injury. This review goes over roles of fibronectin in platelet functions with a focus on fibronectin assembly within developing platelet thrombi.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16839338     DOI: 10.1111/j.1538-7836.2006.01943.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  35 in total

Review 1.  Platelets as crucial partners for tumor metastasis: from mechanistic aspects to pharmacological targeting.

Authors:  Annalisa Contursi; Angela Sacco; Rosalia Grande; Melania Dovizio; Paola Patrignani
Journal:  Cell Mol Life Sci       Date:  2017-05-09       Impact factor: 9.261

2.  Extra-domain B in oncofetal fibronectin structurally promotes fibrillar head-to-tail dimerization of extracellular matrix protein.

Authors:  André Schiefner; Michaela Gebauer; Arne Skerra
Journal:  J Biol Chem       Date:  2012-03-22       Impact factor: 5.157

3.  Plasma fibronectin concentration in inbred mouse strains.

Authors:  Bianca Tomasini-Johansson; Deane F Mosher
Journal:  Thromb Haemost       Date:  2009-12       Impact factor: 5.249

4.  Fibronectin 1 mRNA expression correlates with advanced disease in renal cancer.

Authors:  Sandra Waalkes; Faranaz Atschekzei; Mario W Kramer; Jörg Hennenlotter; Gesa Vetter; Jan U Becker; Arnulf Stenzl; Axel S Merseburger; Andres J Schrader; Markus A Kuczyk; Jürgen Serth
Journal:  BMC Cancer       Date:  2010-09-22       Impact factor: 4.430

5.  Evaluation of cellular fibronectin plasma levels as a useful staging tool in different stages of transitional cell carcinoma of the bladder and renal cell carcinoma.

Authors:  A Hegele; R Hofmann; B Kosche; J Kropf
Journal:  Biomark Insights       Date:  2007-02-07

6.  Elevated plasma fibronectin levels associated with venous thromboembolism.

Authors:  Natalie M Pecheniuk; Darlene J Elias; Hiroshi Deguchi; Patricia M Averell; John H Griffin
Journal:  Thromb Haemost       Date:  2008-08       Impact factor: 5.249

Review 7.  Roles of lysophosphatidic acid in cardiovascular physiology and disease.

Authors:  Susan S Smyth; Hsin-Yuan Cheng; Sumitra Miriyala; Manikandan Panchatcharam; Andrew J Morris
Journal:  Biochim Biophys Acta       Date:  2008-06-10

8.  iso-DGR sequences do not mediate binding of fibronectin N-terminal modules to adherent fibronectin-null fibroblasts.

Authors:  Jielin Xu; Lisa M Maurer; Brian R Hoffmann; Douglas S Annis; Deane F Mosher
Journal:  J Biol Chem       Date:  2010-01-22       Impact factor: 5.157

Review 9.  Dynamic structure of plasma fibronectin.

Authors:  Lisa M Maurer; Wenjiang Ma; Deane F Mosher
Journal:  Crit Rev Biochem Mol Biol       Date:  2016-05-17       Impact factor: 8.250

Review 10.  Fibronectin maintains the balance between hemostasis and thrombosis.

Authors:  Yiming Wang; Heyu Ni
Journal:  Cell Mol Life Sci       Date:  2016-04-21       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.